The Claim
In cognitively unimpaired older adults with elevated amyloid pathology, higher baseline neocortical tau burden measured by PET imaging is associated with a faster rate of cognitive decline over 4.5 years compared to amyloid PET burden, indicating that neocortical tau deposition has greater predictive power for clinical deterioration than amyloid burden alone.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In older adults with early Alzheimer's pathology but no cognitive symptoms, higher levels of tau protein in the outer brain regions predict a faster decline in thinking and memory over 4.5 years, more than levels of amyloid protein.
See the scientific wording
Among cognitively unimpaired older adults with elevated amyloid pathology, higher baseline levels of neocortical tau measured by PET imaging are associated with the most rapid rate of cognitive decline over 4.5 years, surpassing the predictive power of amyloid PET and suggesting that tau deposition in neocortical regions is more directly linked to clinical deterioration than amyloid burden alone.
Amyloid buildup in the brain causes tau proteins to become abnormal and clump together in the outer brain regions. These clumps damage connections between nerve cells and kill nerve cells over time, which directly causes memory and thinking skills to worsen faster than amyloid alone.
What the research says
1 studyIn older people with early Alzheimer’s brain changes but no symptoms yet, the amount of tau protein in the outer brain layers is a better sign of how fast their memory and thinking will get worse than the amount of amyloid plaques.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.